Related Experiment Video
Updated: May 10, 2026
06:11
Production and Purification of Baculovirus for Gene Therapy Application
Published on: April 9, 2018
Evaluating baculovirus as a vector for human prostate cancer gene therapy
Stephanie L Swift1, Guillermo C Rivera, Vincent Dussupt
1Yorkshire Cancer Research Unit, Department of Biology, University of York, Heslington, York, United Kingdom.
Plos One
|June 12, 2013
Summary
Baculovirus (BV) shows promise as a gene therapy vector for prostate cancer, effectively targeting and killing malignant cells within tumors. This insect virus demonstrates preferential transduction of cancer cells, offering a novel approach for non-invasive treatment.
Area of Science:
- Oncology
- Gene Therapy
- Virology
Background:
- Current prostate cancer treatments have limited efficacy.
- Gene therapy offers a potential non-invasive treatment strategy.
- Prostate tumors are heterogeneous, requiring targeted therapies.
Purpose of the Study:
- To evaluate baculovirus (BV) as a novel gene therapy vector for human prostate cancer.
- To assess BV's ability to target multiple cancer cell populations and spare non-malignant cells.
- To investigate BV's efficacy in 3D and in vivo prostate cancer models.
Main Methods:
- In vitro studies using prostate cancer cell lines and primary patient cells (2D and 3D cultures).
- In vivo evaluation in murine prostate cancer xenograft models.
- Assessment of BV transduction efficiency and gene-directed enzyme prodrug therapy (GDEPT) with nitroreductase and CB1954.
Main Results:
- BV preferentially transduced invasive malignant prostate cancer cells over early-stage or non-malignant cells.
- Primary patient-derived prostate cancer cells, especially basal epithelial and stromal cells, were efficiently transduced.
- BV penetrated 3D structures (spheroids, xenografts) and facilitated targeted cell killing via GDEPT.
Conclusions:
- Baculovirus (BV) demonstrates potential as a gene therapy vector for prostate cancer.
- BV effectively targets diverse prostate cancer cell types within heterogeneous tumors.
- BV-mediated GDEPT offers a promising approach for non-invasive prostate cancer treatment.
